| # | Drug | Count |
|---|---|---|
| 0 | VORICONAZOLE | 200 |
| 1 | VORICONAZOLE INJECTION | 192 |
| 2 | PREDNISONE | 157 |
| 3 | TACROLIMUS | 146 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 129 |
| 5 | TACROLIMUS OINTMENT 0.1% | 129 |
| 6 | IBRUTINIB | 113 |
| 7 | PREDNISOLONE | 94 |
| 8 | PREDNISOLONE ORAL | 94 |
| 9 | PREDNISOLONE ORAL SOLUTION | 94 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASPOFUNGIN ACETATE | 12 | 0.0076 |
| 1 | FLUCYTOSINE | 10 | 0.0071 |
| 2 | VORICONAZOLE | 200 | 0.0065 |
| 3 | CHLORAMBUCIL | 25 | 0.0064 |
| 4 | PYRIMETHAMINE | 8 | 0.0063 |
| 5 | AMPHOTERICIN B | 79 | 0.0061 |
| 6 | TOVORAFENIB | 2 | 0.0061 |
| 7 | MICAFUNGIN SODIUM | 40 | 0.0061 |
| 8 | IDARUBICIN HYDROCHLORIDE | 7 | 0.0060 |
| 9 | FOSCARNET SODIUM | 12 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 340 |
| 1 | Azole Antifungal [EPC] | 231 |
| 2 | Kinase Inhibitor [EPC] | 155 |
| 3 | Alkylating Drug [EPC] | 116 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 89 |
| 5 | Polyene Antifungal [EPC] | 87 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 79 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 58 |
| 8 | Echinocandin Antifungal [EPC] | 40 |
| 9 | Glycopeptide Antibacterial [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 10 | 0.0071 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 8 | 0.0063 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 79 | 0.0061 |
| 3 | Echinocandin Antifungal [EPC] | 40 | 0.0049 |
| 4 | Polyene Antifungal [EPC] | 87 | 0.0022 |
| 5 | Azole Antifungal [EPC] | 231 | 0.0015 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 30 | 0.0013 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 21 | 0.0010 |
| 8 | Allylamine Antifungal [EPC] | 7 | 0.0010 |
| 9 | Penem Antibacterial [EPC] | 27 | 0.0008 |